Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth J Pienta

Showing results (231-240 of 519) with videos related to

Pageof 52
Sort By:
The Prostate|August 4, 2019
Polyploid giant cancer cells: Unrecognized actuators of tumorigenesis, metastasis, and resistanceSarah R Amend, Gonzalo Torga, Ke-Chih Lin, et al.
The Journal of Biological Chemistry|December 7, 2007
The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancerJianhua Wang, Yusuke Shiozawa, Jincheng Wang, et al.
Cancer Metastasis Reviews|September 15, 2010
CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progressionXueqing Sun, Guangcun Cheng, Mingang Hao, et al.
Cancer Research|July 31, 2014
Genetic ablation of metadherin inhibits autochthonous prostate cancer progression and metastasisLiling Wan, Guohong Hu, Yong Wei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2010
Inherited variants in the chemokine CCL2 gene and prostate cancer aggressiveness in a Caucasian cohortTong Sun, Lee Gwo-Shu Mary, William K Oh, et al.
Nuclear Medicine Communications|July 14, 2017
Uptake of the prostate-specific membrane antigen-targeted PET radiotracer 18F-DCFPyL in elastofibroma dorsiMichael A Gorin, Wael Marashdeh, Ashley E Ross, et al.
Endocrinology|January 8, 2005
Bone turnover mediates preferential localization of prostate cancer in the skeletonAbraham Schneider, Linda M Kalikin, Ana C Mattos, et al.
Urology Case Reports|February 2, 2019
PSMA-targeted [<sup>18</sup>F]DCFPyL PET/CT-avid lesions in a patient with prostate cancer: Clinical decision-making informed by the PSMA-RADS interpretive frameworkDiane K Reyes, Shadpour Demehri, Rudolf A Werner, et al.
The Prostate|March 10, 2018
PBOV1 as a potential biomarker for more advanced prostate cancer based on protein and digital histomorphometric analysisNeil M Carleton, Guangjing Zhu, Mikhail Gorbounov, et al.
Oncotarget|May 7, 2015
OVOL guides the epithelial-hybrid-mesenchymal transitionDongya Jia, Mohit Kumar Jolly, Marcelo Boareto, et al.
Pageof 52

Showing results (231-240 of 519) with videos related to

Sort By:
Pageof 52
The Prostate|August 4, 2019
Polyploid giant cancer cells: Unrecognized actuators of tumorigenesis, metastasis, and resistanceSarah R Amend, Gonzalo Torga, Ke-Chih Lin, et al.
The Journal of Biological Chemistry|December 7, 2007
The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancerJianhua Wang, Yusuke Shiozawa, Jincheng Wang, et al.
Cancer Metastasis Reviews|September 15, 2010
CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progressionXueqing Sun, Guangcun Cheng, Mingang Hao, et al.
Cancer Research|July 31, 2014
Genetic ablation of metadherin inhibits autochthonous prostate cancer progression and metastasisLiling Wan, Guohong Hu, Yong Wei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2010
Inherited variants in the chemokine CCL2 gene and prostate cancer aggressiveness in a Caucasian cohortTong Sun, Lee Gwo-Shu Mary, William K Oh, et al.
Nuclear Medicine Communications|July 14, 2017
Uptake of the prostate-specific membrane antigen-targeted PET radiotracer 18F-DCFPyL in elastofibroma dorsiMichael A Gorin, Wael Marashdeh, Ashley E Ross, et al.
Endocrinology|January 8, 2005
Bone turnover mediates preferential localization of prostate cancer in the skeletonAbraham Schneider, Linda M Kalikin, Ana C Mattos, et al.
Urology Case Reports|February 2, 2019
PSMA-targeted [<sup>18</sup>F]DCFPyL PET/CT-avid lesions in a patient with prostate cancer: Clinical decision-making informed by the PSMA-RADS interpretive frameworkDiane K Reyes, Shadpour Demehri, Rudolf A Werner, et al.
The Prostate|March 10, 2018
PBOV1 as a potential biomarker for more advanced prostate cancer based on protein and digital histomorphometric analysisNeil M Carleton, Guangjing Zhu, Mikhail Gorbounov, et al.
Oncotarget|May 7, 2015
OVOL guides the epithelial-hybrid-mesenchymal transitionDongya Jia, Mohit Kumar Jolly, Marcelo Boareto, et al.
Pageof 52